Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 501–600 of 1,000
Effect of transdermal nicotine administration on exercise endurance in men
Mündel, T., & Jones, D. A. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033373 · Cited by 41
“…administration leads to increased dopamine cell firing in the ventral tegmental area (Corrigall et al. 1994) and increased dopamine release in the nucleus accumbens (Pontieri et al. 1996), actions which are thought to be critical to the reinforcing properties of nicotine as an addictive drug.”
BackgroundDo caffeine-containing analgesics promote dependence? A review and evaluation
Feinstein, A., Heinemann, L. A., Dalessio, D., Fox, J. M., Goldstein, J., Haag, G., Ladewig, D., & O'Brien, C. P. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110974 · Cited by 44
Evans, N. M., Bose, S., Benedetti, G., Zwart, R., Pearson, K. H., McPhie, G. I., Craig, P. J., Benton, J. P., Volsen, S. G., Sher, E., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01540-1 · Cited by 41
Nicotinic acetylcholine receptors and predisposition to lung cancer
Tournier, J., & Birembaut, P. L. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412ea1 · Cited by 42
Multiple substance use among young males
Kapusta, N. D., Plener, P. L., Schmid, R. W., Thau, K., Walter, H., & Lesch, O. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.007 · Cited by 43
Justinová, Z., Panlilio, L. V., & Goldberg, S. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_13 · Cited by 48
“…anxiolytics, and anesthetics) directly or indirectly elevate extracellular levels of dopamine in the shell of the nucleus accumbens (Brodie et al. 1999; Chen et al. 1990; Masuzawa et al. 2003; Pontieri et al. 1995; Pontieri et al. 1996; Spyraki and Fibiger 1988; van der Laan et al. 1992).”
BackgroundColussi‐Mas, J., & Schenk, S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06467.x · Cited by 43
“The fact that MDMA, like several other drugs of abuse (Pontieri et al., 1995, 1996), preferentially increases DA release in the shell as compared to the core of the NAc (Cadoni et al., 2005) is in line with our results.”
ResultRahman, S., Neugebauer, N. M., Zhang, Z., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.012 · Cited by 40
Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00077-8 · Cited by 42
Pharmacotherapy for smoking cessation: present and future
Aubin, H.-J., Karila, L., & Reynaud, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150837 · Cited by 39
“Inhaled nicotine rapidly distributes to the brain [12, 13] where it interacts with highaffinity nicotinic acetylcholine receptors (nAChRs), resulting in rapid, pulsatile increases in the release of several neurotransmitters, notably dopamine in the mesolimbic system [13-16].”
BackgroundThe role of fatty acid amide hydrolase inhibition in nicotine reward and dependence
Muldoon, P. P., Lichtman, A. H., Parsons, L. H., & Damaj, M. I. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.015 · Cited by 39
“Nicotine exerts its rewarding and reinforcing effects by inducing increased rates of dopaminergic neuron firing in the ventral tegmental area (VTA) (Grenhoff et al., 1986), which leads to increases in dopamine release in the nucleus accumbens (NAc) (Pontieri et al., 1996).”
BackgroundNicotinic antagonist effects on functional attention networks
Thienel, R., Voß, B., Kellermann, T., Reske, M., Halfter, S., Sheldrick, A. J., Radenbach, K., Habel, U., Shah, N. J., Schall, U., et al. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990551 · Cited by 40
“The latter structures are closely linked to the mesolimbic dopamine system (Corrigall et al. 1992 ; Nisell et al. 1994, 1995 ; Pontieri et al. 1996), thus mediating the rewarding and addictive effects of nicotine in smokers (Benowitz, 1992).”
BackgroundFerchmin, P. A., Lukas, R. J., Hann, R. M., Fryer, J. D., Eaton, J. B., Pagán, O. R., Rodríguez, A. D., Nicolau, Y., Rosado, M., Cortés, S., et al. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1049 · Cited by 40
“…rubidium flux; cembranoid binding to nicotinic receptors; nicotine sensitization INTRODUCTION Despite the consensus that nicotine is the compound responsible for the addictive properties of cigarettes (Pontieri et al., 1996), other factors may contribute to this addiction (Clementi et al., 2000).”
BackgroundDopamine D3receptor ligands for the treatment of tobacco dependence
Foll, B. L., Goldberg, S. R., & Sokoloff, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.45 · Cited by 41
“It is well established that nicotine in tobacco – as with alcohol, heroin, cocaine and ∆9-tetrahydrocannabinol in marijuana – elevates dopamine levels in the nucleus accumbens [9,10], a brain structure critically involved in the reinforcing effects of these drugs.”
BackgroundFalk, S., Petersen, J., Svendsen, C., Leguizamón, C. R. R., Jørgensen, S. H., Krauth, N., Ludwig, M. Q., Lundø, K., Roostalu, U., Skovbjerg, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112466 · Cited by 41
“26,30”
BackgroundMethodInfluentialPharmacotherapy of tobacco dependence
Talwar, A., Jain, M., & Vijayan, V. K. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.07.011 · Cited by 40
Massey, S. H., & Compton, M. T. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts142 · Cited by 36
Mereu, M., Chun, L. E., Prisinzano, T. E., Newman, A. H., Katz, J. L., & Tanda, G. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13376 · Cited by 38
“…abused by humans, elicits an increase in DA levels in the NAS, an effect that appears selective or preferential as compared to NAC DA stimulation (Pontieri et al., 1995, 1996; Tanda et al., 1997; Cadoni et al., 2000; Mereu et al., 2015) suggesting that the reinforcing effects of these drugs are…”
BackgroundResultSelf-citationAn Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers
Stein, M. D., Caviness, C. M., Grimone, K., Audet, D., Anderson, B. J., & Bailey, G. L. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv267 · Cited by 40
Temporal Rewiring of Striatal Circuits Initiated by Nicotine
Adermark, L., Morud, J., Lotfi, A., Danielsson, K., Ulenius, L., Söderpalm, B., & Ericson, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.118 · Cited by 39
“Importantly, even though nicotine activates the mesolimbic dopamine system (Adermark et al, 2015; Grenhoff et al, 1986; Nisell et al, 1994b; Pontieri et al, 1996), and has been reported to enhance dopamine levels in the dorsal striatum (Marshall et al, 1997), this is not always the case for the…”
BackgroundMicroarray Technology and its Application on Nicotine Research
Li, M. D., Konu, Ö., Kane, J. K., & Becker, K. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:265 · Cited by 38
Tanda, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4244-7 · Cited by 40
“Detailed anatomical and histological studies of the shell and core sub-regions of the accumbens demonstrated regional differences in their input/output connectivity and in their basic functions, with the shell related to Blimbic^ functions and the core related to somato-motor functions (de Olmos and Heimer 1999; Di Ch…”
BackgroundInfluentialSelf-citationChanges in Tobacco Smoking Following Treatment for Cocaine Dependence
Patkar, A. A., Mannelli, P., Peindl, K., Murray, H. W., Meier, B., & Leone, F. T. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990500479209 · Cited by 38
“These include common forms and routes of administration; and similar effects on mesolimbic dopamine pathways that mediate cue-induced craving (14) leading to the belief that tobacco smoking may be a possible trigger for crack use and vice versa (15).”
BackgroundLecca, D., Shim, I., Costa, E., & Javaid, J. I. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00085-4 · Cited by 39
The Role of Mesoaccumbens Dopamine in Nicotine Dependence
Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 40
“Thus, the effects of acute nicotine on DA overflow in the nucleus accumbens closely resemble those observed for other drugs of dependence (Balfour 2004; Di Chiara 2000; Pontieri et al. 1996).”
BackgroundSocial Defeat Stress, Sex, and Addiction-Like Behaviors
Shimamoto, A. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.009 · Cited by 38
Hamajima, N., Ito, H. M., Matsuo, K., Saito, T., Tajima, K., Ando, M., Yoshida, K., & Takahashi, T. (2002) · Journal of Epidemiology · doi:10.2188/jea.12.297 · Cited by 40
Tsukada, H., Miyasato, K., Nishiyama, S., Fukumoto, D., Kakiuchi, T., & Domino, E. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300745 · Cited by 38
Tonstad, S. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.011 · Cited by 39
“Dopaminergic transmission in the nucleus accumbens is a critical substrate to the process of acquiring and maintaining drug addiction, including nicotine addiction [31,32].”
BackgroundBassareo, V., Cucca, F., Musio, P., Lecca, D., Frau, R., & Chiara, G. D. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12839 · Cited by 36
“Microdialysis and voltammetry studies have shown that shell dopamine (DA) is preferentially activated by drugs of abuse after non-contingent (passive) and contingent exposure (Pontieri et al., 1995, 1996; Tanda et al., 1997; Lecca et al., 2006a,b, 2007a,b; Aragona et al., 2008).”
BackgroundSelf-citationBassareo, V., Talani, G., Frau, R., Porru, S., Rosas, M., Kasture, S. B., Peana, A. T., Loi, E., Sanna, E., & Acquas, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00545 · Cited by 36
Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease.
Busquets, X., MacFarlane, N. G., Heine‐Suñer, D., Morlá, M., Torres‐Juan, L., Iglesias, A., Lladó, J., Sauleda, J., & Agustí, A. G. N. (2007) · PubMed Central · Cited by 35
Varani, A. P., Moutinho, L. M., Bettler, B., & Balerio, G. N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.006 · Cited by 35
Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons
Lanteri, C., Doucet, E. L., Hernàndez-Vallejo, S. J., Godeheu, G., Bobadilla, A., Salomon, L., Lanfumey, L., & Tassin, J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.97 · Cited by 36
Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms
Zawertailo, L. A., Attwells, S., deRuiter, W. K., Le, T. L., Dawson, D., & Selby, P. L. (2020) · Nutrients · doi:10.3390/nu12123834 · Cited by 38
“nucleus accumbens (NAcc) [37], a region thought to contribute to the reinforcing effects of euphoria [38].”
BackgroundXu, X., Wang, J., Aron, A. P., Lei, W., Westmaas, J. L., & Weng, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042235 · Cited by 39
“The brain’s mesolimbic dopaminergic pathway includes the ventral tegmental area (VTA), nucleus accumbens (NAcc), insula, amygdala, medial pre-frontal cortex (mPFC), and dorsal striatum, and plays a key role in addiction [24–29] including nicotine addiction [30–33].”
BackgroundGreen, T. A., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00838-3 · Cited by 38
Cohen, A., Soleiman, M. T., Talia, R., Koob, G. F., George, O., & Mandyam, C. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3685-0 · Cited by 36
“The development of tobacco dependence is considered to be motivated by the reinforcing effects of nicotine, the primary psychoactive and addictive compound found in tobacco (Jaffe and Kanzler 1979; Pich et al. 1997; Pontieri et al. 1996; Stolerman and Jarvis 1995).”
Metabolic Mapping of the Effects of Win 55212–2 Intravenous Administration in the Rat
Pontieri, F. E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00064-0 · Cited by 35
“…9 -tetrahydrocannabinol (THC) or the synthetic cannabinoid agonist WIN 55212–2 increase extracellular dopamine levels in the shell of the rat nucleus accumbens (Tanda et al. 1997), an effect that resembles those produced by psychomotor stimulants, opiates, and nicotine (Pontieri et al. 1995, 1996).”
BackgroundResultSelf-citationMesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
“Like other addictive drugs, nicotine initially increases the basal DA concentration in the NAc shell as measured by microdialysis (Pontieri et al. 1996; Di Chiara 1999; Zhang et al. 2009b).”
BackgroundSimonnet, A., Cador, M., & Caillé, S. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00476.x · Cited by 35
“As with other drugs of abuse, the reinforcing properties of nicotine ultimately involve an increase in DA neurotransmission in the nucleus accumbens (NAC) (Corrigall et al. 1992; Pontieri et al. 1996; Pidoplichko et al. 2004).”
BackgroundDehydroepiandrosterone, its metabolites and ion channels
Hill, M., Dušková, M., & Stárka, L. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.05.006 · Cited by 37
“[23] F.”
BackgroundLiu, X., Hou, Y., Yan, T., Guo, Y., Han, W., Guan, F., Chen, T., & Li, T. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12276 · Cited by 34
Lanteri, C., Hernàndez-Vallejo, S. J., Salomon, L., Doucet, E. L., Godeheu, G., Torrens, Y., Houades, V., & Tassin, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3315-08.2009 · Cited by 37
Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference
Wilar, G., Shinoda, Y., Sasaoka, T., & Fukunaga, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1635-x · Cited by 35
Perceived stress and substance use in methadone-maintained smokers
Moitra, E., Anderson, B. J., & Stein, M. D. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.010 · Cited by 32
“Reasons for this higher ate might be biological (Frosch et al., 2000; Pontieri et al., 1996; chmitz et al., 1994; Spiga et al., 2005; Story and Stark, 1991), ut MMTP patients also often have chronic life stress due to ecoomic challenges, and high rates of unemployment, homelessness, ack of insurance, and history of in…”
New-generation radiotracers for nAChR and NET
Ding, Y., & Fowler, J. S. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.017 · Cited by 34
Erjavec, G. N., Perković, M. N., Borovečki, F., Hajnšek, S., Mück‐Šeler, D., & Pivac, N. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.050 · Cited by 39
Bases neurofisiológicas da dependência do tabaco
Planeta, C. S., & Cruz, F. C. (2005) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832005000500002 · Cited by 64
MARTÍNEZ-RAGA, J., KEANEY, F., SUTHERLAND, G., PEREZ-GALVEZ, B., & STRANG, J. (2003) · Addiction Biology · doi:10.1080/1355621031000069837 · Cited by 34
“This seems to play a crucial role.(4) It has been suggested that the development of withdrawal symptoms may be mediated by noradrenergic neurones in the”
Background(−)-Nornicotine Partially Substitutes for (+)-Amphetamine in a Drug Discrimination Paradigm in Rats
Bardo, M. T., Bevins, R. A., Klebaur, J. E., Crooks, P. A., & Dwoskin, L. P. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00303-1 · Cited by 34
Sun, N., & Laviolette, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.130 · Cited by 35
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Schmidt, H. D., Rupprecht, L. E., & Addy, N. (2018) · Complex Psychiatry · doi:10.1159/000494799 · Cited by 36
Effects of Ethanol on Excitatory and Inhibitory Synaptic Transmission in Rat Cortical Neurons
Moriguchi, S., Zhao, X., Marszalec, W., Yeh, J. Z., & Narahashi, T. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00266.x · Cited by 35
Psychotic symptoms and smoking in 44 countries
Koyanagi, A., Stickley, A., & Haro, J. M. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12566 · Cited by 34
“Furthermore, nicotine may cause activation of mesolimbic dopamine neurotransmission, which in turn, might increase the risk for psychotic symptoms in susceptible individuals (29).”
BackgroundFernander, A., Shavers, V. L., & Hammons, G. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01954.x · Cited by 34
Craving for Alcohol and Drugs in Animals and Humans: Biology and Behavior
Miller, N. S., & Goldsmith, R. J. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_08 · Cited by 37
Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior
Tochigi, M., Suzuki, K., Kato, C., Otowa, T., Hibino, H., Umekage, T., Kato, N., & Sasaki, T. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282e9a51e · Cited by 40
Caffeine and Activation Theory: Effects on Health and Behavior
(2006) · CRC Press eBooks · doi:10.1201/9781420006568 · Cited by 32
Tacke, U., Wolff, K., Finch, E., & Strang, J. (2001) · Addiction Biology · doi:10.1080/13556210020040217 · Cited by 32
Christensen, M. H., Ishibashi, M., Nielsen, M. L., Leonard, C. S., & Kohlmeier, K. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.010 · Cited by 31
The epigenetic effect of nicotine on dopamine D1 receptor expression in rat prefrontal cortex
Gözen, O., Balkan, B., Yildirim, E., Koylu, E. O., & Pöğün, Ş. (2013) · Synapse · doi:10.1002/syn.21659 · Cited by 33
“…et al., 1986); enhances dopamine outflow in the Nucleus Accumbens (NAc) (Di Chiara and Imperato, 1988; Imperato et al., 1986; Nisell et al., 1996; Pontieri et al., 1996; Schilstrom et al., 1998), dorsal STR (Benwell and Balfour, 1997; Janhunen and Ahtee, 2004), and frontal cortex (Liang et al.,…”
BackgroundVerhagen, M., Kleinjan, M., & Engels, R. C. M. E. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.76 · Cited by 36
Associations between drug abuse treatment and cigarette use: Evidence of substance replacement.
Conner, B. T., Stein, J. A., Longshore, D., & Stacy, A. W. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.1.64 · Cited by 29
SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence
Nehlig, A., Armspach, J., & Namer, I. J. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.2/anehlig · Cited by 33
Bouvrais‐Veret, C., Weiss, S., Andrieux, A., Schweitzer, A., McIntosh, J. M., Job, D., Giros, B., & Martres, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.015 · Cited by 33
“hypersensitivity of STOP KO mice to the stimulating locomotor effect of nicotine could be due to an enhanced DA release effect, since nicotine induces DA release in the nucleus accumbens, as all drugs of abuse (Pontieri et al., 1996).”
BackgroundEffects of dopamine receptor antagonists on nicotine-induced attentional enhancement
Hahn, B., Shoaib, M., & Stolerman, I. P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00003 · Cited by 34
Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
Rallis, E. A., Nasiopoulou, A., KOUSKOUKIS, C. E., & Koumantaki, E. (2004) · PubMed · Cited by 34
The acute effects of nicotine on corticostriatal responses to distinct phases of reward processing
Wang, K. S., Zegel, M., Molokotos, E. K., Moran, L. V., Olson, D. P., Pizzagalli, D. A., & Janes, A. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0611-5 · Cited by 30
Luca, M. A. D. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00021 · Cited by 35
“…21 | 1 In contrast, habituation of DA response is not present after repeated exposure to drugs of abuse (e.g., nicotine, opiates, psychostimulants, cannabinoids), which preferentially stimulate DA transmission in NAc shell as compared to NAc core (Pontieri et al., 1995, 1996; Tanda et al., 1997).”
Evidence for the role of nitric oxide in nicotine-induced locomotor sensitization in mice
Ulusu, U., Uzbay, T. I., Kayır, H., ALICI, T., & Karakaş, S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2018-0 · Cited by 31
“Nicotine has behavioral and neurochemical properties similar to other psychostimulants such as amphetamine and cocaine (Bryne 1988; Pointieri et al. 1996).”
BackgroundStimulants as Specific Inducers of Dopamine-Independent σ Agonist Self-Administration in Rats
Hiranita, T., Soto, P. L., Tanda, G., Kopajtic, T. A., & Katz, J. L. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207522 · Cited by 32
Self-citationCarlo, F. D., Vicinelli, M. C., Pettorruso, M., Risio, L. D., Migliara, G., Baccolini, V., Trioni, J., Grant, J. E., Dell’Osso, B. M., & Martinotti, G. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152446 · Cited by 31
Toxicological overview of cigarette smoking on angiogenesis
Ejaz, S., & Lim, C. W. (2005) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2005.03.011 · Cited by 30
Adriani, W., Macrì, S., Pacifici, R., & Laviola, G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00448-x · Cited by 33
Topical Mecamylamine for Diabetic Macular Edema
Campochiaro, P. A., Shah, S. M., Hafiz, G., Heier, J. S., Lit, E. S., Zimmer-Galler, I. E., Channa, R., Nguyen, Q. D., Syed, B., Diana, V., et al. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.12.005 · Cited by 30
“Patients (18 or older) with type 1 or type 2 diabetes and DME were eligible if they had reduction in visual acuity between 20/40 and 20/400 and met the following criteria: (1) center subfield thickness measured by optical coherence tomography (OCT) ≥ 250 μm, (2) no potential contributing causes to reduced visual acuit…”
MethodMaritz, G. S. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809343712 · Cited by 30
“High affinity nAChRs are found in the membranes of normal lung cells and in lung cancer cells of all histological types [Maus et al. 1998; Pontieri et al. 1996; Maneckjee and Minna, 1990].”
BackgroundBracci, L., Ballas, S. K., Spreafico, A., & Neri, P. (1997) · Blood · doi:10.1182/blood.v90.9.3623 · Cited by 30
Graupner, M., Maex, R., & Gutkin, B. S. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003183 · Cited by 32
“VTA [3] boosting dopamine (DA) output to its targets such as the nucleus accumbens [4] and thereby playing a cititcal role in”
BackgroundLÉNA, C., & CHANGEUX, J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11333.x · Cited by 28
Berg, C. J., Wen, H., Cummings, J. R., Ahluwalia, J. S., & Druss, B. G. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12041.x · Cited by 32
Brody, A. L., London, E. D., Olmstead, R. E., Allen-Martinez, Z., Shulenberger, S., Costello, M. R., Abrams, A. L., Scheibal, D., Farahi, J. B., SHOPTAW, S. J., et al. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.06.004 · Cited by 30
Liang, Y., Boules, M., Shaw, A. M., Williams, K., Fredrickson, P. A., & Richelson, E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.037 · Cited by 29
Said, N., Lakehayli, S., Khachibi, M. E., Ouahli, M. E., Nadifi, S., Hakkou, F., & Tazi, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.029 · Cited by 30
Involvement of spinal Met–enkephalin in nicotine-induced antinociception in mice
Kiguchi, N., Maeda, T., Tsuruga, M., Yamamoto, A., Yamamoto, C., Ozaki, M., & Kishioka, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.086 · Cited by 28
Wang, S., Kim, S., Cosgrove, K., & Morris, E. D. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.10.019 · Cited by 28
Castelli, M., Federici, M., Rossi, S., Chiara, V. D., Napolitano, F., Studer, V., Motta, C., Sacchetti, L., Romano, R., Musella, A., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07876.x · Cited by 33
“Effects of cocaine and sucrose on CB1Rs(GABA) in DAT-CI mice Cocaine consumption (Di Chiara & Imperato, 1988; Pontieri et al., 1996) and palatable food such as sucrose activate the DAdependent reward pathway (Hajnal et al., 2004; Mark et al., 1991), and sensitize striatal CB1Rs(GABA) through D2Rs…”
BackgroundThomsen, G. K., Knudsen, G. M., Jensen, P. S., Ziebell, M., Holst, K. K., Asenbaum, S., Booij, J., Darcourt, J., Dickson, J. C., Ozlem Kapucu, L., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-39 · Cited by 28
“are similar to those of other addictive substances [1],”
Presynaptic dopamine modulation by stimulant self-administration
España, R. A., & Jones, S. R. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s371 · Cited by 32
“Thus, in one experiment amphetamine induced a 2-3 fold higher increase in the core than the shell (97), yet the opposite is true in several other studies which show that the shell is more responsive to cocaine and amphetamine than the core (99,103).”
ResultSagheddu, C., Scherma, M., Congiu, M., Fadda, P., Carta, G., Banni, S., Wood, J. T., Makriyannis, A., Malamas, M. S., & Pistis, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.013 · Cited by 27
Middleton, L. S., Apparsundaram, S., King‐Pospisil, K., & Dwoskin, L. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.074 · Cited by 28
“…of nicotine increases dopamine release from its presynaptic terminals in the striatum in a concentration-dependent manner (Andersson et al., 1981;Dwoskin et al., 1999;Kaiser et al., 1998;Ksir et al., 1995;Pontieri et al., 1996;Rowell et al., 1987;Vezina et al., 1992;Westfall et al., 1983).”
BackgroundHayase, T. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-76 · Cited by 27
“Furthermore, because of the overlapped distributions of nAChRs and the targets of other abused drugs such as DA neurons, the targets of addictive psychostimulants, and the similarity of the effects of NC to those of other addictive drugs [18,19], NC is thought to play a role as a trigger for other abused drugs [20].”
BackgroundTobacco Smoking: Current Concepts in Etiology and Treatment
Patkar, A. A., Vergare, M. J., Batra, V., Weinstein, S. P., & Leone, F. T. (2003) · Psychiatry · doi:10.1521/psyc.66.3.183.25159 · Cited by 31
Metabolic Mapping of the Effects of Oral Alcohol Self‐Administration in Rats
Porrino, L. J., Williams‐Hemby, L., Whitlow, C. T., Bowen, C. A., & Samson, H. H. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03635.x · Cited by 27
Nicotine, tobacco and addiction
Shytle, R. D., Silver, A. A., & Sanberg, P. R. (1996) · Nature · doi:10.1038/384018b0 · Cited by 30
Svingos, A. L., Colago, E. E. O., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.1041 · Cited by 33
“Moreover, activation of neurons containing both MOR and nicotinic receptors in the AcbSh may underlie certain neurochemical commonalities between nicotine and opiate addiction and withdrawal (Pontieri et al., 1996; Watkins et al., 2000).”
Lenoir, M., Tang, J. S., Woods, A. S., & Kiyatkin, E. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4940-12.2013 · Cited by 28
Sex heterogeneity in pharmacogenetic smoking cessation clinical trials
Schnoll, R. A., & Patterson, F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.012 · Cited by 26
“Based on previous evidence that nicotine’s rewarding effects aremediated, in part, by dopaminergic mechanisms (e.g., blockade of dopamine reuptake; Pontieri et al., 1996; Balfour, 2002), pharmacogenetic analyses focused on genes in the dopamine reward pathway.”
Hand tremor related to smoking habits and the consumption of caffeine in male industrial workers
ELLINGSEN, D., Bast‐Pettersen, R., Efskind, J., Gjølstad, M., Olsen, R., Thomassen, Y., & Molander, P. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.02.004 · Cited by 26
“Dopamine release in certain brain areas may mediate the reinforcing and addictive properties of nicotine (Corrigall et al., 1994; Pontieri et al., 1996; Tanda and Goldberg, 2000).”
BackgroundOrejarena, M. J., Herrera-Solís, A., Pons, S., Maskos, U., Maldonado, R. J., & Robledo, P. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.011 · Cited by 28
“The results showed that β2KO mice did not reliably acquire nicotine self-administration at any of the doses tested, while WT controls showed dosedependent acquisition of this behaviour. β2-VEC mice readily acquired and maintained nicotine self-administration at the effective dose f 15…”
Background
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.